Literature DB >> 29888527

Dupilumab: short-term effectiveness and security in real clinical practice - A retrospective multicentric study.

R Ruiz-Villaverde1, J Dominguez-Cruz2, J C Armario-Hita3, L Martinez-Pilar4, S Alcantara-Luna5, J J Pereyra-Rodriguez2.   

Abstract

Year:  2018        PMID： 29888527     DOI： 10.1111/jdv.15118

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  9 in total

1.  Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset.

Authors:  Lawrence F Eichenfield; April Armstrong; Emma Guttman-Yassky; Peter A Lio; Chi-Chang Chen; Dionne M Hines; Catherine B McGuiness; Sohini Ganguli; Dimittri Delevry; Debra Sierka; Usha G Mallya
Journal:  Dermatol Ther (Heidelb)       Date:  2022-05-11

2.  Retrospective Study of Dupilumab Treatment for Moderate to Severe Atopic Dermatitis in Korea: Efficacy and Safety of Dupilumab in Real-World Practice.

Authors:  Dong Hyek Jang; Seok Jae Heo; Hye Jung Jung; Mi Yeon Park; Seong Jun Seo; Jiyoung Ahn
Journal:  J Clin Med       Date:  2020-06-24       Impact factor: 4.241

Review 3.  Conjunctivitis in patients with atopic dermatitis treated with dupilumab.

Authors:  Sandra Ferreira; Tiago Torres
Journal:  Drugs Context       Date:  2020-05-04

4.  One-Year Effectiveness and Safety of Dupilumab Treatment for Moderate-to-Severe Atopic Dermatitis in Korean Patients: A Real-World Retrospective Analysis.

Authors:  Hanjae Lee; Bo Ri Kim; Kyu Han Kim; Dong Hun Lee; Jung Im Na
Journal:  Allergy Asthma Immunol Res       Date:  2022-01       Impact factor: 5.764

5.  104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain.

Authors:  Jose Juan Pereyra-Rodriguez; Javier Dominguez-Cruz; Jose Carlos Armario-Hita; Ricardo Ruiz-Villaverde
Journal:  An Bras Dermatol       Date:  2021-09-27       Impact factor: 1.896

Review 6.  A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis.

Authors:  Masahiro Kamata; Yayoi Tada
Journal:  JID Innov       Date:  2021-07-30

7.  Ocular surface disorders associated with the use of dupilumab based on WHO VigiBase.

Authors:  Sunny Park; Jung Hyun Lee; Ji Hyun Park; So Hyang Park; Song Yi Park; Yong Woo Jung; Soo An Choi
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379

8.  Real-world experience of dupilumab in the treatment of moderate-to-severe atopic dermatitis.

Authors:  Nicole S Kim; Khalad Maliyar; Luciana Oliveira; Ashley O'Toole; Melinda J Gooderham
Journal:  Int J Dermatol       Date:  2020-08-09       Impact factor: 2.736

Review 9.  New and Emerging Systemic Treatments for Atopic Dermatitis.

Authors:  Megan Newsom; Arjun M Bashyam; Esther A Balogh; Steven R Feldman; Lindsay C Strowd
Journal:  Drugs       Date:  2020-07       Impact factor: 9.546
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.